SCHEMBL9598366

SCHEMBL9598366

C=CCn1cnc2[c]cccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 2/20 0.37
HPGD P15428 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
CYP3A4 P08684 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4D Q08499 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL326813 0.74 TDP1 (0.63) SMN1; SMN2NPSR1TDP1LMNAL3MBTL1
SCHEMBL2548441 0.73 HTR1A (0.34) HPGDNPC1RAB9ANPSR1ALDH1A1
SCHEMBL4853502 0.73 ADORA2B (0.40) ADORA2BHPGDNPC1RAB9ASMN1; SMN2
Bromide SCHEMBL11005339 0.72 TDP1 (0.61) SMN1; SMN2NPSR1TDP1LMNAL3MBTL1
SCHEMBL2207685 0.72 RAB9A (0.35) RAB9ASMN1; SMN2NPSR1KDM4ELMNA
SCHEMBL8875192 0.71 LTA4H (0.45) ADORA2BHPGDNPC1RAB9ACYP1A2
SCHEMBL7132590 0.71 MEN1 (0.42) HPGDNPC1RAB9AALDH1A1KDM4E
SCHEMBL17962407 0.69 MEN1 (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1MEN1
SCHEMBL19848028 0.69 NPC1 (0.42) ADORA2BHPGDNPC1RAB9ACYP1A2
SCHEMBL5031264 0.69 RAB9A (0.42) ADORA2BHPGDNPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5254595-A Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them ELF SANOFI (FR) 1993-10-19 US disclosed
EP-0200915-B1 AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM Roche Diagnostics GmbH (DE) 1989-09-27 EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 US disclosed
EP-0280951-A1 Amino-propanol derivatives, process for their preparation and medicines containing these compounds, as well as intermediates Roche Diagnostics GmbH (DE) 1988-09-07 EP disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 EP disclosed
US-4391980-A FOR INVERSION OF CONFIGURATION OF OPTICALLY ACTIVE COMPOUNDS CIBA-GEIGY CORPORATION (US) 1983-07-05 US disclosed
US-4294966-A SALT FORMATION CIBA-GEIGY CORPORATION (US) 1981-10-13 US disclosed